CTV News | Health News - Healthy Living & Fitness Articles

Latest Health Reports

  • false
    Dr. Theresa Tam

    Vaccine may not be a 'silver bullet' solution: Dr. Tam warns

    false
    Interrupted sleep

    'COVID-somnia': How the pandemic is interrupting sleep

    false
    CTV National News

    Anonymous and voluntary COVID-19 tracing app released

    false
    Boxes of remdesivir, a medication used to treat the coronavirus, are seen as a lab technician works at the Eva Pharma facility in Cairo, Egypt, Sunday, July 12, 2020. Eva Pharma, a leading Egyptian pharmaceutical company is producing two drugs used in the treatment of COVID-19 patients -- remdesivir for severe cases in intensive care, and avipiravir indicated for moderate cases. (AP / Nariman El-Mofty)

    Remdesivir approved by Health Canada to treat COVID-19

  • Boxes of hydroxychloroquine and chloroquine are seen at the pharmacy of the Nossa Senhora da Conceicao hospital in Porto Alegre, Brazil, on May 26, 2020. (Diego Vara/Reuters/CNN)

    U.S. sent Brazil millions of hydroxychloroquine doses. Months later, they're still in storage

    The Trump administration's donation of 2 million doses of hydroxychloroquine to Brazil has been mostly untouched since arrival, Brazilian officials have told CNN.

CTV News | Health News - Healthy Living & Fitness Articles

Trending Health Topics Obesity Food recall Dementia Face transplants

More Health Stories

In-Depth with Avis Favaro

Avis Favaro, Medical Correspondent

Avis Favaro

CTV's Medical and Health Correspondent is always looking for health information that can make a difference in the lives of Canadians.

  • Rick Smith, the executive director of the Broadbent Institute and co-author of 'Slow Death by Rubber Duck,' experimented on himself to find the presence of microplastics in the human body.

    How one environmentalist set out to detect microplastics in his own body

    Bruno Iozzo celebrates being discharged from the Humber River Hospital after 104 days. (Contributed)

    'It's amazing': Toronto man recovering after 104 days in ICU with COVID-19

    A patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle, on March 16, 2020. (Ted S. Warren / AP)

    The hunt for a vaccine: Canadian company begins human testing of COVID-19 candidate

Most-Read Health Stories



CTV News app

LIVE COVID-19 UPDATES